...
首页> 外文期刊>Heart >High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
【24h】

High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis

机译:高效液相色谱-串联质谱(HP LC-MS / MS)尿液分析显示出很高的抗高血压治疗依从性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objectives Non-adherence to therapy is an important cause of suboptimal blood pressure control but few practical tools exist to accurately and routinely detect it. We used a simple urine-based assay to evaluate the prevalence of antihypertensive treatment non-adherence and its impact on blood pressure in a specialist hypertension centre. Methods 208 hypertensive patients (125 new referrals, 66 follow-up patients with inadequate blood pressure control and 17 renal denervation referrals) underwent assessment of antihypertensive drug intake using high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis at the time of clinical appointment. A total of 40 most commonly prescribed antihypertensive medications (or their metabolites) were screened for in spot urine samples. Results Overall, 25% of patients were totally or partially non-adherent to antihypertensive treatment (total non-adherence 10.1%, partial non-adherence 14.9%). The highest prevalence of partial and total non-adherence was among follow-up patients with inadequate blood pressure control (28.8%) and those referred for consideration of renal denervation (23.5%), respectively. There was a linear relationship between blood pressure and the numerical difference in detected/ prescribed antihypertensive medications-every unit increase in this difference was associated with 3.0 (1.1) mm Hg, 3.1 (0.7) mm Hg and 1.9 (0.7) mm Hg increase in adjusted clinic systolic blood pressure, clinic diastolic blood pressure (DBP) and 24 h mean daytime DBP (p=0.0051, p=8.62×10~6, p=0.0057), respectively. Conclusions Non-adherence to blood pressure lowering therapy is common, particularly in patients with suboptimal blood pressure control and those referred for renal denervation. HP LC-MS/MS urine analysis could be used to exclude non-adherence and better stratify further investigations and intervention.
机译:目的不坚持治疗是导致血压控制不佳的重要原因,但很少有实用工具可以准确,常规地检测到血压。我们使用了一个简单的基于尿液的检测方法来评估抗高血压治疗药物非依从性的患病率及其对专业高血压中心血压的影响。方法采用高效液相色谱-串联质谱(HP LC-MS / MS)对208例高血压患者(125例新转诊患者,66例血压控制不足的随访患者和17例肾去神经支配患者)进行了抗高血压药物摄入评估临床任命时进行分析。在现场尿液样本中共筛选了40种最常用的降压药物(或其代谢物)。结果总体上,25%的患者完全或部分不接受降压治疗(总不依从率为10.1%,部分不依从率为14.9%)。血压控制不充分的随访患者(28.8%)和考虑考虑肾去神经支配的患者(23.5%)的部分和全部不依从发生率最高。血压与检测到的/处方降压药物的数值差异之间存在线性关系,每增加一个单位,血压的增加分别与3.0(1.1)mm Hg,3.1(0.7)mm Hg和1.9(0.7)mm Hg相关调整后的临床收缩压,临床舒张压(DBP)和24小时平均日间DBP(p = 0.0051,p = 8.62×10〜6,p = 0.0057)。结论不坚持降压治疗很常见,尤其是在血压控制不佳的患者和因肾神经支配而转诊的患者中。 HP LC-MS / MS尿液分析可用于排除不依从性并更好地将进一步的调查和干预分层。

著录项

  • 来源
    《Heart》 |2014年第11期|855-861|共7页
  • 作者单位

    Department of Cardiovascular Sciences, University of Leicester, Leicester, UK ,NIHR Leicester Biomedical Research Unit in Cardiovascular Disease, Leicester, UK ,Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Wing, Glenfield Hospital, Leicester, LE3 9QP, UK;

    Department of Cardiovascular Sciences, University of Leicester, Leicester, UK ,NIHR Leicester Biomedical Research Unit in Cardiovascular Disease, Leicester, UK;

    Department of Chemical Pathology, University Hospitals of Leicester NHS Trust, Leicester, UK;

    Department of Cardiovascular Sciences, University of Leicester, Leicester, UK ,NIHR Leicester Biomedical Research Unit in Cardiovascular Disease, Leicester, UK;

    Department of Cardiovascular Sciences, University of Leicester, Leicester, UK;

    Department of Chemical Pathology, University Hospitals of Leicester NHS Trust, Leicester, UK;

    Department of Cardiovascular Sciences, University of Leicester, Leicester, UK ,NIHR Leicester Biomedical Research Unit in Cardiovascular Disease, Leicester, UK;

    Department of Cardiovascular Sciences, University of Leicester, Leicester, UK ,Department of Chemical Pathology, University Hospitals of Leicester NHS Trust, Leicester, UK;

    Department of Chemical Pathology, University Hospitals of Leicester NHS Trust, Leicester, UK;

    Department of Cardiovascular Sciences, University of Leicester, Leicester, UK ,Department of Chemical Pathology, University Hospitals of Leicester NHS Trust, Leicester, UK;

    Institute of Cardiovascular Science and NIHR University College London Hospitals Biomedical Research Centre, University College London, London. UK;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号